The rates of degradation of [3Hileucine-labelled proteins have been measured in cultures of skin fibroblasts obtained from normal controls (five subjects) and patients with Duchenne muscular dystrophy (six subjects). Cultures were incubated with [3Hlleucine (10,uCi/ml) for 60min to label 'short-lived' proteins, and with [3Hlleucine (5,uCi/ml) for 60 h to label 'long-lived' proteins. Optimal wash procedures were devised for removal of [3Hileucine from the extracellular space and from cell pools before beginning degradation measurements. Re-utilization of [3H]leucine released from degraded labelled proteins was prevented by supplementing the medium with 4 mM-leucine. Rates of degradation did not depend on the growth state of the cells or on cell age over the range used (passages eight-20). Degradation of long-lived proteins was approximately linear over a 24h period, at a rate of 1.0% per h. 30% of short-lived protein was degraded within 6h. No differences were observed between protein degradation in normal fibroblasts and in those from patients with Duchenne muscular dystrophy.
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Duchenne muscular dystrophy is a degenerative disorder in which there is a progressive and irrevocable loss of muscle tissue with its replacement by fat and connective tissue. Despite these degenerative changes, muscle regeneration has also been described in Duchenne muscular dystrophy (Cullen & Fulthorpe, 1975) and these paradoxical features of degeneration and regeneration have led to a number of studies of protein synthesis and degradation in dystrophic tissues. Increased autolysis has been described in homogenates of muscle from the dystrophic chick (Iodice et al., 1966) and mouse (129/ReJ-dy/dy; Mayer et al., 1976) and measurements of degradation by tyrosine release in organ baths of dystrophic mouse (C57 BL/6J-dy2J/dy2J) (Libby & Goldberg, 1978) and hamster muscle (Goldspink & Goldspink, 1977; Nakatsu et al., 1978) have indicated increased degradation rates. Using a radioautographic technique, Monkton & Marusyk (1978) claimed that there was increased leucine incorporation in the 129/ReJ-dy/dy mouse in vivo but Kitchin & Watts (1973) , in a careful study with the same mutant, concluded that there was no increased turnover when differences in pool size were taken into account. Monkton & Marusyk (1979) (Weinstock et al., 1958; McCaman, 1963; Tappel et al., 1962; Pennington, 1963) , chicken (Tappel et al., 1962; lodice et al., 1966; Peterson et al., 1972) and human (Kar & Pearson, 1978) (Iodice, 1976; Libby & Goldberg, 1978) . It has since been claimed that the treatment of dystrophic chickens (Connecticut strain) (Stracher et al., 1978) and mice (129/ReJ-dy/dy) (Schorr et al., 1978) led to a significant improvement, although Enomoto & Bradley (1977) Cell cultures have a number of advantages for studies of protein degradation over studies in vivo or measurements made on muscle in organ baths. In these systems there is a delay in the entry and release of labelled materials from the tissue, with consequent problems of re-utilization of released label. It is also difficult to clear the intracellular pools of free-labelled amino acid at the end of the labelling period before beginning the degradation chase. These problems remain in cell-culture methods but are minimized because there is direct and rapid release of label from cells into a very large, excess volume of medium (Poole & Wibo, 1973) . Cell cultures have been used to study changes in protein degradation with culture age (Bradley et al., 1976; Kaftory et al., 1978) , viral transformation (Bradley, 1977; Hendil, 1977; Baxter & Stanners, 1978) , growth state (Bradley, 1977; Castor, 1977; Hendil, 1977;  Robinson, 1977; Baxter & Stanners, 1978) and hormone treatment (Robinson et al., 1976) . We have used the intermittent-perfusion technique described by Bradley et al. (1976) to measure protein degradation in normal and dystrophic human-skin fibroblasts. Previous studies in this laboratory have shown that the rates of protein synthesis are similar in normal and dystrophic cells (Stephens & Dunn, unpublished work).
Materials and methods Cell culture
Cultures of skin fibroblasts were established from patients with Duchenne muscular dystrophy and normal controls with standard methods. Biopsies were taken with informed consent from patients and volunteers. All were grown in plastic flasks (80cm3) with Eagle's minimal essential medium (Paul, 1975) , containing 10% newborn calf serum, 10mM-Hepes* and 50i.u. of penicillin/ml and 50,g of streptomycin/ml (growth medium incubator [02 + CO2 (95: 5, v/v) ]. All tissue culture materials were purchased from Gibco-Biocult, Paisley, Scotland, U.K.
Protein degradation
The standard procedure was as follows: cells were plated in six-well plates at a density of approx. 5 x 105 cells per well. [3HlLeucine (sp. activity, 40-60Ci/mmol; The Radiochemical Centre, Amersham, Bucks., U.K.) (5,Ci/ml, 1.5ml/well) was added to one set of cultures for 60h. At the end of this incubation period, the wells were washed twice with growth medium supplemented with 4mM-leucine (chase medium), incubated for 2h at 370C in the same medium and washed twice again. They were incubated for a further hour during which time a second set of cultures was labelled with [3Hlleucine (lO,Ci/ml, 1.5 ml/well) to label short-lived proteins. At the end of this period, all cultures were washed twice, incubated for two 15min periods and again washed with chase medium. Data will be presented to demonstrate that this procedure depletes intracellular pools of free [3Hlleucine.
When the incubations and washes were completed, 1 ml of chase medium was added to each well and the plates incubated in a CO2 incubator. At 0.5. 1.0. 2.0, 4.0, 6.0 and 12.Oh the medium was removed and replaced with fresh medium (1 ml), but at 24h it was replaced with 5% trichloroacetic acid to extract the remaining labelled leucine in the intracellular pools and the cells dissolved in 1.0 ml of 1.0M-NaOH. To measure free leucine released into the medium, 100u1 of 25% trichloroacetic acid was added to 500,l of each medium sample, precipitated proteins were spun down by centrifuging at 2000g for lOmin and the supernatant was counted. 100ul samples were counted in 3ml of scintillation cocktail (Hydroluma; LKB Instruments, Croydon, Surrey, U.K.) with a Rackbeta scintillation-counter (LKB Instruments) and under these conditions corrections for quenching were were sufficient to reduce counts from these markers to background levels (9-15 c.p.m.).
The removal of free [3Hlleucine from the intracellular pools is not so readily achieved. Robertson & Wheatley (1979) have reported that HeLa cells grown in suspension culture have approx. 70% of their free leucine in a pool that exchanges almost instantaneously with the extracellular medium. We were unable to detect such a freely diffusible pool in human-skin fibroblasts because estimates of the extracellular space based on inulin and polyethylene glycol were greater than that possible for leucine. It is possible that this was due to the relatively small number of cells used and to the difficulties of using monolayers rather than suspension cultures for such studies (Wheatley, D. N., personal communication). The acid-soluble pool of these cells could be removed by repeated washings or short incubations. The rate of appearance of [3Hlleucine in medium containing 0, 0.4 or 4.0mM-leucine and trichloroacetic acid-extractable [3Hlleucine in the cells decreased with time and temperature as shown in Table 1 . Washings and two or four 15 min incubations were ineffective at 0°C compared with 27 and 37°C. The latter was clearly the temperature at which label was most efficiently removed, and as the difference between two and four incubations was small, our standard washing procedure after cell labelling was: two washes, two 15 min incubations at 370C, followed by two further washes, all with medium containing 4 mM-leucine. Prevention ofre-utilization ofreleased label Re-utilization of released [3Hlleucine by the cells will give a spuriously low estimate of protein degradation, and experiments in which protein degradation was measured in medium containing 0, 0.4, 4.0 and 8.0mM-leucine showed that 4.0mM-leucine was sufficient to prevent re-utilization of released labelled leucine. Results are shown in Fig.  1(a) for short-lived and in Fig. 1(b) for long-lived proteins. It is clear that re-utilization did occur when no leucine was present, but that the addition of 0.4 mM-leucine was sufficient to prevent re-utilization during measurement of short-lived protein degradation. However, the difference in degradation of longlived proteins at 24h in medium containing 0.4 and 4.0 mM-leucine was significant (P =0.002 MannWhitney rank sum test) and it was decided to supplement normal growth medium with 4.0mM-leucine for degradation measurements.
Effects of growth state and cell age on protein degradation
Normal cells in culture cease dividing when they reach a certain density and concurrently undergo a variety of metabolic changes; there must be some regulation of the net rate of protein accumulation when cells become density-inhibited, either by inhibition of protein synthesis or by increased protein degradation, or by both means; Balb/3T3 cells for example degrade proteins twice as rapidly when density-inhibited (Neff et al., 1977) . It was important to determine if protein degradation in human-skin fibroblasts was dependent on their state of growth.
Cells were plated at densities of 3 x 105 and 1 x 105 cells per well and degradation of proteins Monolayer cultures were incubated in 1.5 ml of growth medium containing lO,uCi/ml of [3H]leucine for 60min. At the end of this period, the cultures were rapidly washed twice with 2 ml of growth medium (a), followed by two (b) or four (c) 15 min incubations. Washes and incubations were carried out at 0, 27 and 370C. After each procedure 1.0ml of 5% trichloroacetic acid was added to each well to extract the acid-soluble [3Hileucine pools. 100,ul measured 3 days later. Fig. 2 shows that for these cells protein degradation was the same for growing and density-inhibited cultures. Bradley (1977) obtained similar results with the human embryoniccell strain WI-38, although Castor (1977) demonstrated a small increase in degradation rates (from 1.0 to 1.5%) in confluent cultures of the same cell type. To reduce variation to a minimum, in our experiments cultures were always used when confluent. Changes in protein degradation have also been reported with increasing cell age in culture (Bradley et al., 1976; Kaftory et al., 1978) but these changes were found only in very late passage, phase III, senescent cells. To avoid differences due to cell age, we used cultures between passages eight and 20, and found no correlation of protein degradation with cell age over this range. Protein degradation in normal and dystrophic cells Details of the sources of cells and numbers of experiments performed are given in Table 2 and a summary of results is given in Table 3 . In Table 3 , only values for 2, 6 and 24 h are given although degradation at the intermediate time points of 0.5, 1, 4 and 12h was also measured. Rates of degradation of short-lived and long-lived proteins in these experiments were as shown in Fig. 2 . The degradation of short-lived proteins was very rapid over the first 6h with about 30% of labelled protein degraded in this period. Over the rest of the chase period, the rate of release of [3Hlleucine was greatly reduced with only a further 16% of short-lived proteins degraded over 18 h. Degradation of longlived proteins in these cells was almost linear over the whole 24 h period, with about 1.0% of total long-lived proteins degraded per hour. These results indicate that a fraction of proteins labelled during the short-term labelling period were degraded at rates similar to those for long-lived proteins.
It is difficult to compare these data directly with those of other studies because 'short-lived' and 'long-lived' proteins are defined by the labelling procedure and the subsequent washing and incubation schedules, and the terms 'short-labelled' and 'long-labelled' might be more appropriate. In our experiments long-lived proteins are those that retain label after a 60h labelling period followed by a 4h chase in cold medium and short-lived proteins are those labelled for 1 h followed by a 0.5 h chase in cold medium. Others have labelled short-lived proteins for as short as 25 min (Bradley et al., 1976) and long-lived proteins for six generations followed by a 20min cold chase (Baxter & Stanners, 1978) . Nevertheless, our results are in agreement with other studies, e.g., Robinson et al. (1976) obtained a degradation rate of 1.3% per h for long-lived proteins and 24% of short-lived proteins were degraded by 6h. Our results indicate that protein degradation in dystrophic skin fibroblasts does not differ from that in normal fibroblasts. The results shown in Table 3 cannot be compared by Student's t test or analysis of variance because the variances of the two groups are significantly different. An analysis by using the non-parametric MannWhitney test to compare pooled results for normal and dystrophic experiments (13 experiments in each group) showed no significant differences between the two groups at any time (P > 0.1).
Ideally these experiments should be performed with muscle cells, but we have used skin fibroblasts because these can be grown in large numbers, they are a relatively homogeneous population and have been shown to be abnormal in Duchenne muscular dystrophy (Jones & Witkowski, 1979) . These negative results obtained with skin fibroblasts do not conflict with the published results in which increased protein degradation has been demonstrated in dystrophic muscle (Goldspink & Goldspink, 1977; Libby & Goldberg, 1978; Nakatsu et al., 1978) . However, having established that this technique is sufficiently reproducible, we now feel confident in applying the method to the small numbers of dystrophic muscle-cell cultures that are available to us, and these experiments are in progress.
